| DODGX | IVKIX | DODGX / IVKIX | |
| Total Expense Ratio | 0.51 | 0.72 | 71% |
| Annual Report Gross Expense Ratio | 0.51 | 0.90 | 57% |
| Fund Existence | 62 years | 24 years | - |
| Gain YTD | 8.036 | 2.116 | 380% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 123B | 232M | 53,017% |
| Annual Yield % from dividends | 1.04 | 1.17 | 89% |
| Returns for 1 year | 8.24 | 7.35 | 112% |
| Returns for 3 years | 111.44 | 17.08 | 652% |
| Returns for 5 years | 163.47 | 17.22 | 949% |
| Returns for 10 years | 476.28 | 64.82 | 735% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TTEQ | 42.13 | 0.49 | +1.16% |
| T. Rowe Price Technology ETF | |||
| SNAV | 38.72 | 0.31 | +0.81% |
| Mohr Sector Nav ETF | |||
| SCHY | 32.66 | 0.09 | +0.28% |
| Schwab International Dividend Equity ETF | |||
| EXEQ | 27.52 | N/A | N/A |
| Wedbush ReturnOnLdrsp(R)U.S.Large-CapETF | |||
| LFSC | 45.33 | -0.04 | -0.10% |
| F/m Emerald Life Sciences Innovation ETF | |||